我們已在上線! 進一步了解
SLGCW

SomaLogic Warrant

已下市

SLGCW已於2024年1月5日下市。

 

公司簡介: SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

員工: 451

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於SLGCW的最新新聞文章。

價格圖表採用Lightweight Charts™實作